Muscle loss may predict CAR-T outcomes in lymphoma
NCT ID NCT06156774
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is observing 130 adults with B-cell non-Hodgkin lymphoma who are scheduled to receive CAR-T cell therapy. Researchers want to see if having low muscle mass (sarcopenia) affects how well the treatment works or causes more side effects. The goal is to learn whether simple muscle assessments can help predict outcomes, but this study does not test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA,B CELL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
A.O. Ospedali Riuniti Villa Sofia-Cervello - Divisione di Ematologia
RECRUITINGPalermo, Italy
Contact Email: •••••@•••••
-
A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C.D.U. Ematologia
RECRUITINGAlessandria, Italy
Contact Email: •••••@•••••
-
A.O.U. Citta della Salute e della Scienza di Torino - S.C. Ematologia
RECRUITINGTorino, Italy
Contact Email: •••••@•••••
-
AOU Integrata di Verona - U.O. Ematologia
RECRUITINGVerona, Italy
Contact Email: •••••@•••••
-
AOU Ospedali Riuniti - Clinica di Ematologia
RECRUITINGAncona, Italy
Contact Email: •••••@•••••
-
AOU Pisana - U.O. Ematologia
NOT_YET_RECRUITINGPisa, Italy
Contact Email: •••••@•••••
-
ASST Grande Ospedale Metropolitano Niguarda - S.C. Ematologia
RECRUITINGMilan, Italy
Contact Email: •••••@•••••
-
ASST Spedali Civili di Brescia - S.C. Ematologia
RECRUITINGBrescia, Italy
Contact Email: •••••@•••••
-
Azienda Ospedaliera S .Giuseppe Moscati - S.C. Ematologia e Trapianto emopoietico
RECRUITINGAvellino, Italy
Contact Email: •••••@•••••
-
Azienda Ospedaliera Universitaria Careggi - Unità funzionale di Ematologia
RECRUITINGFlorence, Italy
Contact Email: •••••@•••••
-
Azienda Sanitaria Universitaria Friuli Centrale (ASU FC) - Clinica di Ematologia
RECRUITINGUdine, Italy
Contact Email: •••••@•••••
-
Azienda Unità Sanitaria Locale-IRCCS - Arcispedale Santa Maria Nuova - Ematologia
RECRUITINGReggio Emilia, Italy
Contact Email: •••••@•••••
-
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano - Ematologia
RECRUITINGMilan, Italy
Contact Email: •••••@•••••
-
Fondazione Policlinico Universitario A. Gemelli IRCCS - Università Cattolica S. Cuore - Ematologia
RECRUITINGRoma, Italy
Contact Email: •••••@•••••
-
IRCCS Centro di Riferimento Oncologico di Aviano - Divisione di Oncologia e dei Tumori immuto-correlati
RECRUITINGAviano, Italy
Contact Email: •••••@•••••
-
Istituto Scientifico San Raffaele - Unità Linfomi - Dipartimento Oncoematologia
RECRUITINGMilan, Italy
Contact Email: •••••@•••••
-
Ospedale Guglielmo da Saliceto - U.O. Ematologia
RECRUITINGPiacenza, Italy
Contact Email: •••••@•••••
-
Ospedale S. Maria della Misericordia - Ematologia
RECRUITINGPerugia, Italy
Contact Email: •••••@•••••
-
Ospedale di Castelfranco Veneto - Oncoematologia IOV
RECRUITINGCastelfranco Veneto, Italy
Contact Email: •••••@•••••
-
Policlinico Umberto I - Università "La Sapienza" - Istituto Ematologia -Dipartimento di Medicina Traslazionale e di Precisione
RECRUITINGRoma, Italy
Contact Email: •••••@•••••
-
ULSS 8 Berica - Ospedale S. Bortolo - Ematologia
RECRUITINGVicenza, Italy
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Engineered immune cells take on tough blood cancers
- Lymphoma Patients' vaccine response under scrutiny
- New CAR-T therapy targets Hard-to-Treat lymphoma
- Off-the-Shelf cell therapy takes on tough lymphoma
- New liquid biopsy could spot hidden brain lymphoma
- New hope for Tough-to-Treat lymphoma: Two-Drug combo enters Mid-Stage trial